Keywords: aventis, vertex, enroll, patients, phase, iib, pralnacasan

Aventis and Vertex enroll patients in Phase IIb pralnacasan RA study

Article | 21 July 2003

Print This

Franco-German drugs major Aventis and Vertex Pharmaceuticals of the USA say they have begun enrollment into a Phase IIb clinical ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in